Importantly, both low-dose and high dose of L-arabinose further decreased mRNA level of Elovl3 (Figure 5A), suggesting that the alleviation of HFD-induced metabolic syndrome by L-arabinose might be mediated by suppressing long-chain fatty acid synthesis in liver. This evidence concerns the gene ELOVL3 and metabolic syndrome.